Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaporized Cannabis for Neuropathic Pain
NCT01037088Phase 2Completed
- Sponsor
- University of California, Davis
- Start
- Dec 2009
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabis in neuropathic pain (3 arms), sponsored by University of California, Davis. Primary endpoint: Participants With 30% or Greater Reduction in Pain Intensity. Started Dec 2009; status: completed.
02
Drugs
cannabis
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT01037088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01037088.